Patents by Inventor William W. Ruehl

William W. Ruehl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for survival curve shifting in dogs
    Patent number: 5565495
    Abstract: Selegiline, or a pharmaceutically acceptable salt form of selegiline, is administered to mammals commencing at a point in time at which at least 50% of the mammal's life span is completed, with the administration continuing on a periodic but regular basis over the remaining life span of the mammal. The treatment, which shifts the survival curve, is especially useful for dogs.
    Type: Grant
    Filed: September 6, 1994
    Date of Patent: October 15, 1996
    Assignee: Deprenyl Animal Health, Inc.
    Inventors: David R. Stevens, William W. Ruehl
  • Treating hearing loss with deprenyl
    Patent number: 5561163
    Abstract: Selegiline and pharmaceutically acceptable analog forms thereof are used as treatments for hearing loss in mammals, especially dogs.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 1, 1996
    Assignee: Deprenyl Animal Health, Inc.
    Inventors: William W. Ruehl, David R. Stevens
  • Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
    Patent number: 5192808
    Abstract: A method of treating Cushing's Disease comprising treating mammals, and especially humans, dogs, horses or ponies with from 0.01 to about 4.0 mg/kg of body weight of L-Deprenyl, preferably daily, to achieve and maintain remission.
    Type: Grant
    Filed: March 27, 1992
    Date of Patent: March 9, 1993
    Assignee: Deprenyl Animal Health, Inc.
    Inventors: William W. Ruehl, David S. Bruyette, David Stevens